Healthcare -
Biotechnology - NASDAQ - US
$ 22.04
-0.136 %
$ 3.74 B
Market Cap
-9.97
P/E
IMVT - TOTAL CURRENT LIABILITIES
Total Current Liabilities IMVT - Immunovant, Inc.
48.6 M
LAST VALUE
4.49%
2 YEAR CAGR
163.80%
5 YEAR CAGR
0.00%
10 YEAR CAGR